Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London
Zen Technologies shares gain over 3% after securing Indian patent in defence tech
'Namazvad, not Samajwad': BJP attacks Tejashwi for 'will bin Waqf Act' remark; says 'won't happen'
German foreign minister makes inaugural visit to Kiev